Literature DB >> 104929

Immunopharmacology of gold sodium thiomalate and auranofin (SK&F D-39162): effects on cell-mediated immunity.

D T Walz, D E Griswold.   

Abstract

The effects of gold sodium thiomalate (GST) and auranofin (SK&F D-39162) on cell-mediated immunity were investigated using oxazolone-induced contact sensitivity and delayed hypersensitivity to sheep red blood cells. C57Bl mice were sensitized to oxazolone on day 0 and challenged either 45 or 72 h later. The resulting paw edema was read plethysmographically 24 h after challenge. GST and auranofin both were capable of stimulating oxazollone-induced contact sensitivity which was compromised by using a shortened sensitization period (45 h). Auranofin but not GST stimulated the response to oxazolone in immunosuppressed mice, but neither agent significantly altered the uncompromised response in normal mice. The stimulatory effect of auranofin and GST on cell-mediated immunity was corroborated using SRBC to induce delayed hypersensitivity. Comparison of blood Au levels revealed that gold in the form of auranofin was approximately 4x more effective in stimulating cell-mediated immunity than was gold in the form of GST. These results were suggested to be due to the possible stimulation by gold of T effector as well as T suppressor lymphocytes, thus explaining the condition dependency of the immunoregulation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104929     DOI: 10.1007/bf00910733

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  GOLD THERAPY IN RHEUMATOID ARTHRITIS: A REVIEW OF TEN YEARS' TREATMENT.

Authors:  C M MARSHALL
Journal:  Med J Aust       Date:  1965-08-07       Impact factor: 7.738

2.  The effect of levamisole on cell-mediated immunity and suppressor cell function.

Authors:  D Sampson; A Lui
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

3.  Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial.

Authors: 
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

Review 4.  [Gold salts in rheumatoid arthritis: half a century of therapeutic use].

Authors:  C Cervini
Journal:  Clin Ter       Date:  1977-06-30

5.  Suppressor T cells in tolerance to non-self and self antigens.

Authors:  A Basten; R Loblay; E Chia; R Callard; H Pritchard-Briscoe
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

6.  Effect of auranofin, a new antiarthritic agent, on immune complex-induced release of lysosomal enzymes from human leukocytes.

Authors:  A E Finkelstein; F R Roisman; D T Walz
Journal:  Inflammation       Date:  1977-06       Impact factor: 4.092

7.  Selective inhibition of prostaglandin biosynthesis by gold salts and phenylbutazone.

Authors:  K J Stone; S J Mather; P P Gibson
Journal:  Prostaglandins       Date:  1975-08

8.  Auranofin. New oral gold compound for treatment of rheumatoid arthritis.

Authors:  A E Finkelstein; D T Walz; V Batista; M Mizraji; F Roisman; A Misher
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

9.  Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1978-03       Impact factor: 4.092

10.  Condition-dependent immunoregulatory control of contact sensitivity by levamisole.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

View more
  5 in total

Review 1.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

2.  Effect of selected immunoregulatory agents on low-grade contact sensitivity.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

3.  Action of gold salts in some inflammatory and immunological models.

Authors:  A J Lewis; J Cottney; D D White; P K Fox; A McNeillie; J Dunlop; W E Smith; D H Brown
Journal:  Agents Actions       Date:  1980-04

4.  Auranofin-induced suppression of autoimmune antibody production and inflammation in genetically autoimmune-prone mice.

Authors:  H Friedman; S Specter; T Klein; C Newton; M Rivenbark; D Rowlands; D T Walz
Journal:  Inflammation       Date:  1990-08       Impact factor: 4.092

5.  Effect of auranofin on antibody-dependent cellular cytotoxicity (ADCC) mediated by rat peripheral blood polymorphonuclear leukocytes and mononuclear cells.

Authors:  M J DiMartino; D T Walz
Journal:  Inflammation       Date:  1980-09       Impact factor: 4.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.